z-logo
open-access-imgOpen Access
Reported Benefits of Insulin Therapy for Better Glycemic Control in Type 2 Diabetic Patients–-Is this Applicable in Saudi Patients?
Author(s) -
Wafaa Alsaggaf,
Mohammed Asiri,
Balgees A. Ajlan,
Alaa Afif,
Roaa Khalil,
Anas Bin Salman,
Ahmed Mohammed Alghamdi,
Osama Bashawieh,
Atheer Alamoudi,
Abeer Aljahdali,
Nouf Aljahdali,
Hussam Patwa,
Mohammed Bakhaidar,
Suhad Bahijri,
Maimoona Ahmed,
Khalid Z. Alshali,
Samia A Bokhari,
Amani Alhozali,
Anwar Borai,
Ghada Ajabnoor,
Jaakko Tuomilehto
Publication year - 2016
Publication title -
clinical medicine insights endocrinology and diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 15
ISSN - 1179-5514
DOI - 10.4137/cmed.s38077
Subject(s) - medicine , glycemic , insulin , diabetes mellitus , blood pressure , lipid profile , type 2 diabetes mellitus , type 2 diabetes , endocrinology
To compare the effect of different treatment regimens (oral hypoglycemic agents [OHGs], insulin therapy, and combination of both) on glycemic control and other cardiometabolic risk factors in type 2 diabetes mellitus (T2DM) patients in Saudi.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom